Pre‐clinical evaluation of a laser system with emission control based on stone vs soft tissue recognition
BJU International · 2026-08 · 138 (2) · 267-275
DOI: 10.1111/bju.70301 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift BJU International, online erschienen am 31.05.2026. Verfasst von Olivier Traxer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Service d'Urologie, AP-HP Hôpital Tenon, Paris, France. Hauptthemen laut MEDLINE: Lithotripsy, Laser, Kidney Calculi. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: IPG photonics.
Abstract (Originalsprache)
Objective
To evaluate the feasibility and performance of the StoneSense™ module (SSM; IPG Medical, Marlborough, MA, USA), a prototype real‐time target recognition unit integrated into a IPG Thulium Fiber Laser (TFL). Materials and Methods The SSM analyses the spectral signature of back reflected light‐emitting diode (LED) light from the target, stopping laser energy emission when incoming signal is originating from tissue or when the fibre‐to‐target distance is larger than pre‐defined threshold (typically, ≥2–4 mm). The ex vivo tests were conducted on artificial BegoStone phantoms ((Bego GmbH & Co. KG, Bremen, Germany) embedded in porcine kidney tissue using energy settings of 0.1–2 J and 5–100 Hz at two fibre‐scanning speeds (1 and 3 mm/s) through a translation stage movement. Human urinary stones were subsequently tested at 2 and 5 mm/s with setting of 0.5 J × 20 Hz. The in vivo trial was conducted by lithotripsy of pre‐implanted human stones in porcine urinary tract. Primary outcome measures included ablation efficiency as well as specificity and sensitivity of stone recognition.
Results
Soft tissue ablation was completely prevented in all the ex vivo trials while maintaining high lithotripsy efficiency. Mean stone ablation reduction was 2.75% and 3% at fibre scanning speeds of 1 and 3 mm/s, respectively. The system achieved 100% sensitivity and up to 98% specificity in inhibiting laser emission to soft tissue. In vivo , complete dusting with fragments
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service d'Urologie, AP-HP Hôpital Tenon, Paris, France.
- Group Recherche Clinique n°20, Sorbonne Université, Paris, France.
- Research and Development, IPG Medical, Marlborough, MA, USA.
- Research and Development, VPG Laser One, Fryazino, Russia.
- Urology Center of the Central Clinical Hospital of Civil Aviation, Moscow, Russia.
ORCID-Profile: Olivier Traxer, Federico Zorzi
Förderung
- IPG photonics
Zitieren
APA
Traxer, O., Zorzi, F., Yaroslavsky, I. V., Kovalenko, A., Andreeva, V., Childs, J., Martov, A. G., & Altshuler, G. (2026). Pre‐clinical evaluation of a laser system with emission control based on stone vs soft tissue recognition. BJU International, 138(2), 267-275. https://doi.org/10.1111/bju.70301
Vancouver
Traxer O, Zorzi F, Yaroslavsky IV, Kovalenko A, Andreeva V, Childs J, et al. Pre‐clinical evaluation of a laser system with emission control based on stone vs soft tissue recognition. BJU International. 2026;138(2):267-275. doi:10.1111/bju.70301
BibTeX
@article{Traxer2026,
author = {Traxer, Olivier and Zorzi, Federico and Yaroslavsky, IIya V and Kovalenko, Anastasia and Andreeva, Viktoriya and Childs, James and Martov, Alexey G and Altshuler, Gregory},
title = {Pre‐clinical evaluation of a laser system with emission control based on stone vs soft tissue recognition},
journal = {BJU International},
year = {2026},
volume = {138},
number = {2},
pages = {267--275},
doi = {10.1111/bju.70301}
}
EUVIMED